Form 4: iRhythm Technologies Executive Acquires Shares Through Employee Stock Purchase Plan and Receives Restricted Stock Units

Marc Rosenbaum, Chief Accounting Officer of iRhythm Technologies, reports acquiring shares through the company's employee stock purchase plan and receiving restricted stock units.

Summary

• Marc W. Rosenbaum, Chief Accounting Officer of iRhythm Technologies, Inc., filed a Form 4 detailing changes in beneficial ownership.
• He acquired 226 shares of common stock on November 30, 2023, at a price of $72.49 per share through the company's Employee Stock Purchase Plan (ESPP).
• He acquired 280 shares of common stock on May 31, 2024, at a price of $74.98 per share through the company's Employee Stock Purchase Plan (ESPP).
• Rosenbaum also acquired 3,141 restricted stock units (RSUs) on February 26, 2025, which vest in four equal annual installments starting March 1, 2026.
• Following these transactions, Rosenbaum beneficially owns 11,821 shares of iRhythm Technologies common stock.

Sentiment

Score: 7

Explanation: The document reflects standard executive compensation practices, indicating a stable and incentivized management team. The sentiment is neutral to slightly positive.

Positives

• The acquisition of shares through the ESPP demonstrates the executive's investment in the company's future.
• The granting of RSUs aligns the executive's interests with long-term shareholder value creation.

Future Outlook

The vesting schedule of the RSUs indicates a multi-year commitment from the executive to the company.

Industry Context

Executive stock ownership is a common practice in publicly traded companies to align management's interests with those of shareholders. ESPPs and RSU grants are typical components of executive compensation packages.

Comparison to Industry Standards

• Executive compensation packages, including stock options and restricted stock units, are standard practice among publicly traded companies, particularly in the technology and healthcare sectors.
• Companies like Medtronic, Boston Scientific, and Abbott Laboratories also utilize similar compensation strategies to incentivize their executives.
• The vesting schedules and amounts of equity grants are generally benchmarked against peer companies to ensure competitiveness and alignment with performance goals.

Stakeholder Impact

• Shareholders may view the executive's increased stake in the company positively, as it aligns management's interests with shareholder value.
• Employees may be motivated by the availability of an Employee Stock Purchase Plan.

Key Dates